Pulmonary delivery of liposomes co-loaded with SN38 prodrug and curcumin for the treatment of lung cancer

被引:18
作者
Gao, Chengzhi [1 ]
Zhang, Lanfang [2 ]
Xu, Minhao [1 ]
Luo, Yi [1 ]
Wang, Ben [1 ]
Kuang, Meiyan [1 ]
Liu, Xingyou [1 ]
Sun, Meng [1 ]
Guo, Yue [1 ]
Teng, Lesheng [3 ]
Wang, Chenhui [2 ]
Zhang, Yan [2 ]
Xie, Jing [1 ]
机构
[1] Chongqing Univ Technol, Sch Pharm & Bioengn, 69 Hongguang Rd, Chongqing 400054, Peoples R China
[2] Chongqing Univ, Innovat Drug Res Ctr, Sch Pharmaceut Sci, Chongqing Key Lab Nat Prod Synth & Drug Res, 55 South Daxuecheng Rd, Chongqing 401331, Peoples R China
[3] Jilin Univ, Sch Life Sci, 2699 Qianjin Rd, Changchun 130012, Peoples R China
关键词
Pulmonary delivery; SN38; Curcumin; Lung cancer; MICROFLUIDIC SYNTHESIS; NANOPARTICLES; DOXORUBICIN; ACID;
D O I
10.1016/j.ejpb.2022.08.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A co-delivery system of SN38 (7-ethyl-10-hydroxyl camptothecin) prodrug and CUR (curcumin) was designed for the treatment of lung cancer by pulmonary delivery. SN38 was linked to cell-penetrating peptide (CPP) TAT via a polyethylene glycol (PEG) linker to form the SN38 prodrug (TAT-PEG-SN38). Liposomes co-loaded with amphiphilic TAT-PEG-SN38 and curcumin (Lip-TAT-PEG-SN38/CUR) were successfully prepared by a micro -fluidic method for the treatment of lung cancer via pulmonary delivery. Lip-TAT-PEG-SN38/CUR showed nanometer-sized sphericity and a particle size of 171.21 nm. Besides, Lip-TAT-PEG-SN38/CUR exhibited enhanced antiproliferative effect, increased cell apoptosis induction and improved cell cycle arrest compared to the single agents in vitro. The combination induced significant tumor inhibition in a BALB/c mouse lung cancer model. These results indicated that our SN38 prodrug and curcumin co-delivery system was a promising candidate for lung cancer treatment.
引用
收藏
页码:156 / 165
页数:10
相关论文
共 36 条
[1]   Anticancer Effect of Alginate-chitosan Hydrogel Loaded with Curcumin and Chrysin on Lung and Breast Cancer Cell Lines [J].
Abbasalizadeh, Farhad ;
Alizadeh, Effat ;
Fazljou, Seyyed Mohammad Bagher ;
Torbati, Mohammadali ;
Akbarzadeh, Abolfazl .
CURRENT DRUG DELIVERY, 2022, 19 (05) :600-613
[2]   Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes [J].
Bhutani, Whit Kumar ;
Bishnoi, Mahendra ;
Kulkarni, Shrinivas K. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 92 (01) :39-43
[3]   Clinical pharmacokinetics of irinotecan [J].
Chabot, GG .
CLINICAL PHARMACOKINETICS, 1997, 33 (04) :245-259
[4]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[5]   Curcumin and cancer: barriers to obtaining a health claim [J].
Devassy, Jessay G. ;
Nwachukwu, Ifeanyi D. ;
Jones, Peter J. H. .
NUTRITION REVIEWS, 2015, 73 (03) :155-165
[6]   Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects [J].
Du, Yawei ;
Zhang, Wei ;
He, Ruiyu ;
Ismail, Muhammad ;
Ling, Longbing ;
Yao, Chen ;
Fu, Zhenglin ;
Li, Xinsong .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (12) :3247-3258
[7]   Chemopreventive and therapeutic effects of curcumin [J].
Duvoix, A ;
Blasius, R ;
Delhalle, S ;
Schnekenburger, M ;
Morceau, F ;
Henry, E ;
Dicato, M ;
Diederich, M .
CANCER LETTERS, 2005, 223 (02) :181-190
[8]   Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules [J].
Farkhani, Samad Mussa ;
Valizadeh, Alireza ;
Karami, Hadi ;
Mohammadi, Samane ;
Sohrabi, Nasrin ;
Badrzadeh, Fariba .
PEPTIDES, 2014, 57 :78-94
[9]   Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs [J].
Gandhy, Shruti U. ;
Kim, KyoungHyun ;
Larsen, Lesley ;
Rosengren, Rhonda J. ;
Safe, Stephen .
BMC CANCER, 2012, 12
[10]   Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development [J].
Gerrits, CJH ;
deJonge, MJA ;
Schellens, JHM ;
Stoter, G ;
Verweij, J .
BRITISH JOURNAL OF CANCER, 1997, 76 (07) :952-962